✦ LIBER ✦

Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with erlotinib

✍ Scribed by Grace K. Dy, Jeffrey R. Infante, S. Gail Eckhardt, Silvia Novello, Wen Wee Ma, Suzanne F. Jones, Anne Huff, Qiong Wang, A. Benjamin Suttle, Lone H. Ottesen, Alex A. Adjei, Howard A. Burris III…show all 12hide

Book ID: 120966743
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 238 KB
Volume: 31
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-012-9887-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase Ib trial of the oral angiogenesis

Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with pemetrexed in patients with advanced solid tumors

✍ Jeffrey R. Infante, Silvia Novello, Wen Wee Ma, Grace K. Dy, Johanna C. Bendell, 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 265 KB

9137 Phase Ib trial (NCT00619424, VEG109

9137 Phase Ib trial (NCT00619424, VEG109607) of pazopanib (GW786034) and erlotinib administered concurrently

✍ Adjei, A.; Infante, J.; Eckhardt, S.G.; Novello, S.; Jones, S.; Dy, G.; Huff, A. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

A phase I clinical trial of the matrix m

A phase I clinical trial of the matrix metalloproteinase inhibitor, marimastat, administered concurrently with carboplatin, to patients with relapsed ovarian cancer

✍ Thomas, H.; Adams, M. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 288 KB

401 POSTER A phase I study of enzastauri

401 POSTER A phase I study of enzastaurin (ENZ), an oral PKC inhibitor, in combination with erlotinib (ERL) administered orally daily to patients with advanced solid malignancies

✍ H.A. Wakelee; S.K. Padda; L. Chhatwani; M. San Pedro-Salcedo; Y. Krupitskaya; L. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Phase 1 trial of the oral AKT inhibitor

Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors

✍ L Rhoda Molife,Li Yan,Joanna Vitfell-Rasmussen… 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 389 KB

Phase 1 study of the investigational, or

Phase 1 study of the investigational, oral angiogenesis inhibitor motesanib in Japanese patients with advanced solid tumors

✍ Yasuhito Fujisaka; Yasuhide Yamada; Noboru Yamamoto; Toshio Shimizu; Yutaka Fuji 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 364 KB